Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2004 Dec;75(6):1149-54.
doi: 10.1086/426460.

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation

Affiliations
Case Reports

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation

Jiong Tao et al. Am J Hum Genet. 2004 Dec.

Abstract

Recently, we showed that truncation of the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene caused mental retardation and severe neurological symptoms in two female patients. Here, we report that de novo missense mutations in CDKL5 are associated with a severe phenotype of early-onset infantile spasms and clinical features that overlap those of other neurodevelopmental disorders, such as Rett syndrome and Angelman syndrome. The mutations are located within the protein kinase domain and affect highly conserved amino acids; this strongly suggests that impaired CDKL5 catalytic activity plays an important role in the pathogenesis of this neurodevelopmental disorder. In view of the overlapping phenotypic spectrum of CDKL5 and MECP2 mutations, it is tempting to speculate that these two genes play a role in a common pathogenic process.

PubMed Disclaimer

Figures

Figure  1
Figure 1
CDKL5 mutation c.455G→T (p.C152F) in family 1. A, Pedigree for family 1. B, Patient II:2 at the age of 6.5 years. C, Sequence chromatograms from family members I:1, I:2, and the proband (II:2). The affected nucleotide is indicated by a blackened arrow.
Figure  2
Figure 2
CDKL5 mutation c.525A→T (p.R175S) in family 2. A, Pedigree for family 2. The index patient (II:2) is indicated by a blackened arrow. B, Affected twin sisters (II:2 and II:3) at the age of 41 years. Note stereotypic hand movements of the proband (II:2). C, Sequence chromatograms from the family members. From left to right: father (I:1), mother (I:2), unaffected sister (II:1), the index patient (II:2), and her MZ sister (II:3). The affected nucleotide is indicated by a blackened arrow.
Figure  3
Figure 3
Multiple sequence alignment of human CDKL5 with its vertebrate orthologs and with closely related human protein kinases CDKL1, CDKL2, and CDKL3 in the region of the kinase subdomains VII and VIII (see the ClustalW Web site). In the alignment, the residues that differ from the consensus sequence are shown with a gray background. The invariant DFG motif in subdomain VII and the substrate recognition sequence YVATRWYR in subdomain VIII are boxed. Affected amino acids are indicated by a blackened arrow. Amino acid substitutions are shown above the alignment.

References

Electronic-Database Information

    1. BLAST, http://www.ncbi.nlm.nih.gov/BLAST/ (for searching short, nearly exact matches of FDFG sequence)
    1. ClustalW, http://www.ebi.ac.uk/clustalw/ (for alignment of human CDKL5, its orthologs, and closely related CDKL1, CDKL2, and CDKL3)
    1. GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for human genomic sequence containing CDKL5 [accession numbers AL109798 and Z92542], human CDKL5 cDNA [accession number NM_003159], human CDKL5 protein [accession number NP_003150], mouse Cdkl5 [accession number XP_356367], Fugu Cdkl5/Stk9 [accession number AAD28798], human CDKL1 [accession number NP_004187], human CDKL2 [accession number NP_003939], and human CDKL3 [accession number NP_057592])
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for RTT) - PubMed

References

    1. Bourdon V, Philippe C, Labrune O, Amsallem D, Arnould C, Jonveaux P (2001) A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Hum Genet 108:43–50 - PubMed
    1. Buyse IM, Fang P, Hoon KT, Amir RE, Zoghbi HY, Roa BB (2000) Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet 67:1428–1436 - PMC - PubMed
    1. Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ (1997) Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90:859–869 - PubMed
    1. Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML, Vance JM, Pericak-Vance MA (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 28:205–211 - PubMed
    1. Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clarke A (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 9:1119–1129 - PubMed

Publication types

MeSH terms